114 related articles for article (PubMed ID: 12781184)
1. A study on the synthesis of antiangiogenic (+)-coronarin A and congeners from (+)-sclareolide.
Oh S; Jeong IH; Shin WS; Lee S
Bioorg Med Chem Lett; 2003 Jun; 13(12):2009-12. PubMed ID: 12781184
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activity of (+)-hedychilactone A and its analogs from (+)-sclareolide.
Oh S; Jeong IH; Shin WS; Wang Q; Lee S
Bioorg Med Chem Lett; 2006 Mar; 16(6):1656-9. PubMed ID: 16384699
[TBL] [Abstract][Full Text] [Related]
3. Concise syntheses of coronarin A, coronarin E, austrochaparol and pacovatinin A.
Miyake T; Uda K; Kinoshita M; Fujii M; Akita H
Chem Pharm Bull (Tokyo); 2008 Mar; 56(3):398-403. PubMed ID: 18310958
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of symmetrical bis-alkynyl or alkyl pyridine and thiophene derivatives and their antiangiogenic activities.
Ahn CM; Shin WS; Bum Woo H; Lee S; Lee HW
Bioorg Med Chem Lett; 2004 Aug; 14(15):3893-6. PubMed ID: 15225692
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationship of diarylamide derivatives as selective inhibitors of the proliferation of human endothelial cells.
Ogita H; Isobe Y; Takaku H; Sekine R; Goto Y; Misawa S; Hayashi H
Bioorg Med Chem; 2002 Nov; 10(11):3473-80. PubMed ID: 12213461
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic potential of camptothecin and topotecan.
Clements MK; Jones CB; Cumming M; Daoud SS
Cancer Chemother Pharmacol; 1999; 44(5):411-6. PubMed ID: 10501915
[TBL] [Abstract][Full Text] [Related]
7. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
8. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
Yeh CH; Peng HC; Yang RS; Huang TF
Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
Chen HH; Zhou HJ; Wu GD; Lou XE
Pharmacology; 2004 May; 71(1):1-9. PubMed ID: 15051917
[TBL] [Abstract][Full Text] [Related]
10. Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation.
Shim JS; Kim DH; Jung HJ; Kim JH; Lim D; Lee SK; Kim KW; Ahn JW; Yoo JS; Rho JR; Shin J; Kwon HJ
Bioorg Med Chem; 2002 Sep; 10(9):2987-92. PubMed ID: 12110321
[TBL] [Abstract][Full Text] [Related]
11. Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation.
Shim JS; Kim DH; Jung HJ; Kim JH; Lim D; Lee SK; Kim KW; Ahn JW; Yoo JS; Rho JR; Shin J; Kwon HJ
Bioorg Med Chem; 2002 Aug; 10(8):2439-44. PubMed ID: 12057633
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiangiogenic activity of thioacetal artemisinin derivatives.
Oh S; Jeong IH; Ahn CM; Shin WS; Lee S
Bioorg Med Chem; 2004 Jul; 12(14):3783-90. PubMed ID: 15210144
[TBL] [Abstract][Full Text] [Related]
13. Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities.
Chillemi F; Francescato P; Ragg E; Cattaneo MG; Pola S; Vicentini L
J Med Chem; 2003 Sep; 46(19):4165-72. PubMed ID: 12954068
[TBL] [Abstract][Full Text] [Related]
14. Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells.
Abe M; Inoue D; Matsunaga K; Ohizumi Y; Ueda H; Asano T; Murakami M; Sato Y
J Cell Physiol; 2002 Jan; 190(1):109-16. PubMed ID: 11807817
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic activity of tocotrienol.
Inokuchi H; Hirokane H; Tsuzuki T; Nakagawa K; Igarashi M; Miyazawa T
Biosci Biotechnol Biochem; 2003 Jul; 67(7):1623-7. PubMed ID: 12913317
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of a novel nonsteroidal-specific endothelial cell proliferation inhibitor.
Schmidt JM; Tremblay GB; Pagé M; Mercure J; Feher M; Dunn-Dufault R; Peter MG; Redden PR
J Med Chem; 2003 Apr; 46(8):1289-92. PubMed ID: 12672229
[TBL] [Abstract][Full Text] [Related]
17. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
18. Conformation-activity relationship on novel 4-pyridylmethylthio derivatives with antiangiogenic activity.
Honda T; Tajima H; Kaneko Y; Ban M; Inaba T; Takeno Y; Okamoto K; Aono H
Bioorg Med Chem Lett; 2008 May; 18(9):2939-43. PubMed ID: 18420406
[TBL] [Abstract][Full Text] [Related]
19. Neridronate inhibits angiogenesis in vitro and in vivo.
Ribatti D; Nico B; Mangieri D; Maruotti N; Longo V; Vacca A; Cantatore FP
Clin Rheumatol; 2007 Jul; 26(7):1094-8. PubMed ID: 17106617
[TBL] [Abstract][Full Text] [Related]
20. Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis in vitro and in vivo.
Hori A; Imaeda Y; Kubo K; Kusaka M
Cancer Lett; 2002 Sep; 183(1):53-60. PubMed ID: 12049814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
